ATS 2019 Virtual Final Program

813 Patient Classification Either by Severity of Illness or Risk for Mortality Predicts Mortality and Length of Stay/ H. Edriss, S. Yang, K.M. Nugent, Lexington, KY, p.A5667 814 Factors Predicting Mortality in Patients Infected with Human Immunodeficiency Virus (HIV) Admitted to the Medical Intensive Care Unit/ C. McBride, S.M. Lloyd, A. Afzal, H.M. El Sahly, D.K. Narendra, N.A. Hanania, Houston, TX, p.A5668 815 Long-Term Quality of Life and Functional Status Outcomes of Survivors of Critical Illness Enrolled in ICU Nutrition and Exercise Intervention Study/ S.R. Wappel, O. Ali, Z. Nagaria, D. Tran, H. Patel, O. Kolesnik, A.C. Verceles, Baltimore, MD, p.A5669 816 Long-Term Cognitive, Psychological, and Disability Outcomes of Survivors of Chronic Critical Illness/ B. Curtis, S.S. Carson, I.S. Douglas, C.T.L. Hough, J.M. Kahn, D.B. White, F. Ding, G. Tang, J. Jackson, N.E. Brummel, P. Pandharipande, E.W. Ely, T.D. Girard, Pittsburgh, PA, p.A5670 817 Correlation Among Electrical Activity of the Respiratory and Accessory Muscles with Pulmonary Function, Respiratory Muscle Strength, Overall Muscle Strength and Activity Level in Patients After Discharge from the Intensive Care Unit/ C. Fu, Sao Paulo, Brazil, p.A5671 818 Impact of Volatile Anesthetics for Long-Term Sedation in Critically Ill Patients on Cognitive Impairment at 3-Months Follow-Up/ K.D. Walczak, V. Otero Castro, D. Grewal, A. Jerath, M. Wasowicz, N.D. Ferguson, A.C. Steel, M.E. Wilcox, Toronto, Canada, p.A5672 819 Associations Between Markers of Inflammation and Frailty in Survivors of Hospitalization for Critical Illness/ N.E. Brummel, T.D. Girard, C.G. Hughes, J.L. Thompson, R. Chandrasekhar, L.B. Ware, J.B. McNeil, P.P. Pandharipande, E.W. Ely, Nashville, TN, p.A5673 820 Predictors of Functional Decline Among Older Intensive Care Unit (ICU) Survivors/ L.E. Ferrante, T.E. Murphy, B.C. Vander Wyk, L.S. Leo-Summers, M.A. Pisani, T.M. Gill, New Haven, CT, p.A5674 821 Pre-Hospital Frailty and Cognitive Impairment in Older Adult Survivors of Intensive Care: An Observational Cohort Study/ A.A. Hope, J. Verghese, M.N. Gong, Bronx, NY, p.A5675 822 The Relationship Between Frailty and Outcomes in Elderly Patients Suffering In-Hospital Cardiac Arrest/ J.D. Salciccioli, M.C. Casasola, J. Boise, P. Patel, A. Coker, J. Watson, M. Donnino, K. Berg, Cambridge, MA, p.A5676 823 Outcomes After a Simulated, 4-Day Time-Limited Trial of Mechanical Ventilation: An Observational Study/ T. VanKerkhoff, P.A. Reyfman, R.G. Wunderink, J.M. Kruser, Chicago, IL, p.A5677 824 Mathematical Model Predicting Level of Care for Patients Admitted from the Emergency Department Does Not Perform Better than Physician Assessment/ S. Almaaitah, G. Khirfan, B. Hu, M. Rothberg, A. Brateanu, Cleveland, OH, p.A5678 CLINICAL • TRANSLATIONAL RAPID: RAPID ABSTRACT POSTER DISCUSSION SESSION C104 THE MODERN PEDIATRIC PULMONARY FUNCTION LAB: NEW STANDARDS AND NEW TESTS 2:15 p.m. - 4:15 p.m. OMNI DALLAS DOWNTOWN Trinity Ballroom 1-3 (Level 3) Abstract Summaries 2:15-2:45 Viewing/Discussion 2:45-4:15 Chairing: M. Rosenfeld, MD, Seattle, WA L.C. Lands, MD, PhD, ATSF, Montreal, Canada S. Stanojevic, PhD, Toronto, Canada 901 Validation of the FEV1/FVC Cutoff in Ethnically Diverse Children/ P.F. Huang, A.M. Zeiger, S.S. Oh, J.R. Elhawary, L.A. Samedy, T. Elliott, M.A. LeNoir, J. Rodriguez-Santana, T.J. Nuckton, E.G. Burchard, San Francisco, CA, p.A5679 902 Prevalence of Lung Function Abnormalities and Associated Risk factors among School Aged Children in an African City/ C.I. Ndukwu, O.B. Ozoh, B.M. Ale, A.C. Ayuk, J.C. Elo-Ilo, Awka, Nigeria, p.A5680 903 Bronchodilator Reversibility Cutoffs for Persistent Asthma in Ethnically Diverse Children/ A.M. Zeiger, P.F. Huang, S.S. Oh, J.R. Elhawary, L.-A.C. Samedy, T. Elliott, M.A. LeNoir, J.R. Rodriguez-Santana, T.J. Nuckton, E.G. Burchard, San Francisco, CA, p.A5681 904 Bronchodilator Response in Children with Cystic Fibrosis Pulmonary Exacerbations/ M. Pollak, D. Wilson, M. Klingel, M. Solomon, H. Grasemann, Toronto, Canada, p.A5682 905 Measurement of Fractional Exhaled Nitric Oxide (FeNO) Helps Differentiate Between Asthmatic and Non-Asthmatic Etiologies of Dyspnea in Children/ O.J. Lakser, N. Srdanovic, J.M. Salazar, Chicago, IL, p.A5683 906 Measurement of Fractional Exhaled Nitric Oxide (FeNO) May Help Differentiate Between Asthmatic and Non-Asthmatic Etiologies of Chronic Cough in Children/ O.J. Lakser, N. Srdanovic, J.M. Salazar, Chicago, IL, p.A5684 907 Exhaled Nitric Oxide as a Predictor of Exercise Induced Bronchoconstriction in Children with Well Controlled Asthma/ K. Sanchez, P.E. Yaniv, R.P. Garofano, A.M. Layton, M.P. Pierce, M.S. Perzanowski, A.G. Rundle, R.L. Miller, M. Kattan, S. Lovinsky-Desir, New York, NY, p.A5685 908 Fractional Exhaled Nitric Oxide Measurement in Pediatric Postural Tachycardia Syndrome/ H. Emanuel, S. Hashmi, A. Yadav, M. Numan, K. Boukas, R.A. Mosquera, Houston, TX, p.A5686 909 SF6And N2MBW in a Healthy Infant, Preschool and School-Aged Control Population/ P.D. Robinson, A. Lindblad, L. Kadar, S. Kjellberg, M. Rosberg, P. Gustafsson, Sydney, Australia, p.A5687 ATS 2019 • Dallas, TX TUESDAY • MAY 21 303 TUESDAY AFTERNOON